Exploring the Potential Role of CYP2C19 Genetic Variability in Cenobamate Treatment
<b>Background:</b> Cenobamate is a novel antiseizure medication with potential interactions involving cytochrome P450 enzymes, including CYP2C19. Genetic variability in CYP2C19 may influence drug metabolism and tolerability, although its clinical relevance in cenobamate-treated patients remains uncl...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
MDPI AG
2026-06-01
|
| Sraith: | Applied Sciences |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/2076-3417/16/11/5679 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|